Literature DB >> 24900469

Analysis of Flexibility and Hotspots in Bcl-xL and Mcl-1 Proteins for the Design of Selective Small-Molecule Inhibitors.

Chao-Yie Yang1, Shaomeng Wang1.   

Abstract

Although Bcl-xL and Mcl-1, two antideath Bcl-2 members, have similar, flexible binding sites, they can achieve high binding selectivity to endogenous binding partners and synthetic small-molecule inhibitors. Here, we employed molecular dynamic (MD) simulations and hotspot analysis to investigate the conformational flexibility of these proteins and their binding hotspots at the binding sites. Backbone flexibility analyses indicate that the highest degree of flexibility in Mcl-1 is the α4 helical segment as opposed to the α3 helix in Bcl-xL among four helical segments in their binding sites. Furthermore, common and unique binding hotspots at both proteins were identified using small-molecule probes. These analyses can aid the design of potent and specific small-molecule inhibitors for these proteins.

Entities:  

Keywords:  Bcl-xL; Mcl-1; backbone flexibility; binding selectivity; cosolvent molecular dynamics simulation

Year:  2012        PMID: 24900469      PMCID: PMC4025761          DOI: 10.1021/ml200301w

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  17 in total

1.  Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies.

Authors:  A M Petros; D G Nettesheim; Y Wang; E T Olejniczak; R P Meadows; J Mack; K Swift; E D Matayoshi; H Zhang; C B Thompson; S W Fesik
Journal:  Protein Sci       Date:  2000-12       Impact factor: 6.725

2.  Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function.

Authors:  Lin Chen; Simon N Willis; Andrew Wei; Brian J Smith; Jamie I Fletcher; Mark G Hinds; Peter M Colman; Catherine L Day; Jerry M Adams; David C S Huang
Journal:  Mol Cell       Date:  2005-02-04       Impact factor: 17.970

3.  Crystal structure of ABT-737 complexed with Bcl-xL: implications for selectivity of antagonists of the Bcl-2 family.

Authors:  E F Lee; P E Czabotar; B J Smith; K Deshayes; K Zobel; P M Colman; W D Fairlie
Journal:  Cell Death Differ       Date:  2007-06-15       Impact factor: 15.828

4.  Computational analysis of protein hotspots.

Authors:  Chao-Yie Yang; Shaomeng Wang
Journal:  ACS Med Chem Lett       Date:  2010-03-25       Impact factor: 4.345

5.  Hydrophobic Binding Hot Spots of Bcl-xL Protein-Protein Interfaces by Cosolvent Molecular Dynamics Simulation.

Authors:  Chao-Yie Yang; Shaomeng Wang
Journal:  ACS Med Chem Lett       Date:  2011-01-13       Impact factor: 4.345

6.  Determinants of BH3 binding specificity for Mcl-1 versus Bcl-xL.

Authors:  Sanjib Dutta; Stefano Gullá; T Scott Chen; Emiko Fire; Robert A Grant; Amy E Keating
Journal:  J Mol Biol       Date:  2010-04-02       Impact factor: 5.469

7.  The structure of a Bcl-xL/Bim fragment complex: implications for Bim function.

Authors:  Xinqi Liu; Shaodong Dai; Yanan Zhu; Philippa Marrack; John W Kappler
Journal:  Immunity       Date:  2003-09       Impact factor: 31.745

8.  Crystal structure of the Bcl-XL-Beclin 1 peptide complex: Beclin 1 is a novel BH3-only protein.

Authors:  Adam Oberstein; Philip D Jeffrey; Yigong Shi
Journal:  J Biol Chem       Date:  2007-03-02       Impact factor: 5.157

Review 9.  Small-molecule inhibitors of protein-protein interactions.

Authors:  Thorsten Berg
Journal:  Curr Opin Drug Discov Devel       Date:  2008-09

10.  The MCL-1 BH3 helix is an exclusive MCL-1 inhibitor and apoptosis sensitizer.

Authors:  Michelle L Stewart; Emiko Fire; Amy E Keating; Loren D Walensky
Journal:  Nat Chem Biol       Date:  2010-06-20       Impact factor: 15.040

View more
  17 in total

Review 1.  In silico structure-based approaches to discover protein-protein interaction-targeting drugs.

Authors:  Woong-Hee Shin; Charles W Christoffer; Daisuke Kihara
Journal:  Methods       Date:  2017-08-09       Impact factor: 3.608

2.  A novel small-molecule inhibitor of mcl-1 blocks pancreatic cancer growth in vitro and in vivo.

Authors:  Fardokht Abulwerdi; Chenzhong Liao; Meilan Liu; Asfar S Azmi; Amro Aboukameel; Ahmed S A Mady; Thippeswamy Gulappa; Tomasz Cierpicki; Scott Owens; Tao Zhang; Duxin Sun; Jeanne A Stuckey; Ramzi M Mohammad; Zaneta Nikolovska-Coleska
Journal:  Mol Cancer Ther       Date:  2013-09-09       Impact factor: 6.261

3.  Structure-based design of N-substituted 1-hydroxy-4-sulfamoyl-2-naphthoates as selective inhibitors of the Mcl-1 oncoprotein.

Authors:  Maryanna E Lanning; Wenbo Yu; Jeremy L Yap; Jay Chauhan; Lijia Chen; Ellis Whiting; Lakshmi S Pidugu; Tyler Atkinson; Hala Bailey; Willy Li; Braden M Roth; Lauren Hynicka; Kirsty Chesko; Eric A Toth; Paul Shapiro; Alexander D MacKerell; Paul T Wilder; Steven Fletcher
Journal:  Eur J Med Chem       Date:  2016-02-04       Impact factor: 6.514

Review 4.  Driving Structure-Based Drug Discovery through Cosolvent Molecular Dynamics.

Authors:  Phani Ghanakota; Heather A Carlson
Journal:  J Med Chem       Date:  2016-08-17       Impact factor: 7.446

5.  AlphaSpace 2.0: Representing Concave Biomolecular Surfaces Using β-Clusters.

Authors:  Joseph Katigbak; Haotian Li; David Rooklin; Yingkai Zhang
Journal:  J Chem Inf Model       Date:  2020-02-11       Impact factor: 4.956

6.  Application of Site-Identification by Ligand Competitive Saturation in Computer-Aided Drug Design.

Authors:  Himanshu Goel; Anthony Hazel; Wenbo Yu; Sunhwan Jo; Alexander D MacKerell
Journal:  New J Chem       Date:  2021-11-29       Impact factor: 3.591

7.  Structure-based assessment and druggability classification of protein-protein interaction sites.

Authors:  Lara Alzyoud; Richard A Bryce; Mohammad Al Sorkhy; Noor Atatreh; Mohammad A Ghattas
Journal:  Sci Rep       Date:  2022-05-13       Impact factor: 4.996

8.  Computational Cosolvent Mapping Analysis Leads to Identify Salicylic Acid Analogs as Weak Inhibitors of ST2 and IL33 Binding.

Authors:  Xinrui Yuan; Krishnapriya Chinnaswamy; Jeanne A Stuckey; Chao-Yie Yang
Journal:  J Phys Chem B       Date:  2022-03-16       Impact factor: 3.466

9.  BcL-xL conformational changes upon fragment binding revealed by NMR.

Authors:  Clémentine Aguirre; Tim Ten Brink; Olivier Walker; Florence Guillière; Dany Davesne; Isabelle Krimm
Journal:  PLoS One       Date:  2013-05-23       Impact factor: 3.240

10.  The novel BH3 α-helix mimetic JY-1-106 induces apoptosis in a subset of cancer cells (lung cancer, colon cancer and mesothelioma) by disrupting Bcl-xL and Mcl-1 protein-protein interactions with Bak.

Authors:  Xiaobo Cao; Jeremy L Yap; M Karen Newell-Rogers; Chander Peddaboina; Weihua Jiang; Harry T Papaconstantinou; Dan Jupitor; Arun Rai; Kwan-Young Jung; Richard P Tubin; Wenbo Yu; Kenno Vanommeslaeghe; Paul T Wilder; Alexander D MacKerell; Steven Fletcher; Roy W Smythe
Journal:  Mol Cancer       Date:  2013-05-16       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.